Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Cynamon

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
The American Journal of Psychiatry|June 1, 1975
Intentional isoniazid overdosage among southwestern American IndiansM L Sievers, M H Cynamon, T E Bittker
Antimicrobial Agents and Chemotherapy|October 19, 2000
Evaluation of rifalazil in a combination treatment regimen as an alternative to isoniazid-rifampin therapy in a mouse tuberculosis modelA M Lenaerts, S E Chase, M H Cynamon
Journal of Medicinal Chemistry|August 16, 1996
Quantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid estersK E Bergmann, M H Cynamon, J T Welch
Antimicrobial Agents and Chemotherapy|February 1, 1994
Comparative in vivo activities of rifabutin and rifapentine against Mycobacterium avium complexS P Klemens, M A Grossi, M H Cynamon
Antimicrobial Agents and Chemotherapy|April 4, 1998
In vitro antimycobacterial activity of 5-chloropyrazinamideM H Cynamon, R J Speirs, J T Welch
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 30, 2000
Durable cure for tuberculosis: rifalazil in combination with isoniazid in a murine model of Mycobacterium tuberculosis infectionC M Shoen, M S DeStefano, M H Cynamon
Hospital Formulary|May 11, 1982
An aminoglycoside policy directed at use and costM H Cynamon, K K Kallet, D E Zacher
Antimicrobial Agents and Chemotherapy|August 1, 1995
In vitro activities of PS-15, a new dihydrofolate reductase inhibitor, and its cyclic metabolite against Mycobacterium avium complexS C Meyer, S K Majumder, M H Cynamon
Antimicrobial Agents and Chemotherapy|November 1, 1992
Activity of clarithromycin against Mycobacterium avium complex infection in beige miceS P Klemens, M S DeStefano, M H Cynamon
Antimicrobial Agents and Chemotherapy|October 1, 1994
Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine modelS P Klemens, M A Grossi, M H Cynamon
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
The American Journal of Psychiatry|June 1, 1975
Intentional isoniazid overdosage among southwestern American IndiansM L Sievers, M H Cynamon, T E Bittker
Antimicrobial Agents and Chemotherapy|October 19, 2000
Evaluation of rifalazil in a combination treatment regimen as an alternative to isoniazid-rifampin therapy in a mouse tuberculosis modelA M Lenaerts, S E Chase, M H Cynamon
Journal of Medicinal Chemistry|August 16, 1996
Quantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid estersK E Bergmann, M H Cynamon, J T Welch
Antimicrobial Agents and Chemotherapy|February 1, 1994
Comparative in vivo activities of rifabutin and rifapentine against Mycobacterium avium complexS P Klemens, M A Grossi, M H Cynamon
Antimicrobial Agents and Chemotherapy|April 4, 1998
In vitro antimycobacterial activity of 5-chloropyrazinamideM H Cynamon, R J Speirs, J T Welch
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 30, 2000
Durable cure for tuberculosis: rifalazil in combination with isoniazid in a murine model of Mycobacterium tuberculosis infectionC M Shoen, M S DeStefano, M H Cynamon
Hospital Formulary|May 11, 1982
An aminoglycoside policy directed at use and costM H Cynamon, K K Kallet, D E Zacher
Antimicrobial Agents and Chemotherapy|August 1, 1995
In vitro activities of PS-15, a new dihydrofolate reductase inhibitor, and its cyclic metabolite against Mycobacterium avium complexS C Meyer, S K Majumder, M H Cynamon
Antimicrobial Agents and Chemotherapy|November 1, 1992
Activity of clarithromycin against Mycobacterium avium complex infection in beige miceS P Klemens, M S DeStefano, M H Cynamon
Antimicrobial Agents and Chemotherapy|October 1, 1994
Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine modelS P Klemens, M A Grossi, M H Cynamon
Pageof 7